This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (52)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Aging/ Geriatrics  • Nutritional and Metabolic Disorders  • Nutritional and Metabolic Disorders, Other  • Pathology & Laboratory Medicine  • Obesity  • Randomized Controlled Trial  • Alert me on articles by topic  Social Bookmarking   What's this?

A Randomized Controlled Trial

Dennis T. Villareal, MD; John O. Holloszy, MD

JAMA. 2004;292:2243-2248.

Context  Dehydroepiandrosterone (DHEA) administration has been shown to reduce accumulation of abdominal visceral fat and protect against insulin resistance in laboratory animals, but it is not known whether DHEA decreases abdominal obesity in humans. DHEA is widely available as a dietary supplement without a prescription.

Objective  To determine whether DHEA replacement therapy decreases abdominal fat and improves insulin action in elderly persons.

Design and Setting  Randomized, double-blind, placebo-controlled trial conducted in a US university-based research center from June 2001 to February 2004.

Participants  Fifty-six elderly persons (28 women and 28 men aged 71 [range, 65-78] years) with age-related decrease in DHEA level.

Intervention  Participants were randomly assigned to receive 50 mg/d of DHEA or matching placebo for 6 months.

Main Outcome Measures  The primary outcome measures were 6-month change in visceral and subcutaneous abdominal fat measured by magnetic resonance imaging and glucose and insulin responses to an oral glucose tolerance test (OGTT).

Results  Of the 56 men and women enrolled, 52 underwent follow-up evaluations. Compliance with the intervention was 97% in the DHEA group and 95% in the placebo group. Based on intention-to-treat analyses, DHEA therapy compared with placebo induced significant decreases in visceral fat area (–13 cm² vs +3 cm², respectively; P = .001) and subcutaneous fat (–13 cm² vs +2 cm², P = .003). The insulin area under the curve (AUC) during the OGTT was significantly reduced after 6 months of DHEA therapy compared with placebo (–1119 µU/mL per 2 hours vs +818 µU/mL per 2 hours, P = .007). Despite the lower insulin levels, the glucose AUC was unchanged, resulting in a significant increase in an insulin sensitivity index in response to DHEA compared with placebo (+1.4 vs –0.7, P = .005).

Conclusion  DHEA replacement could play a role in prevention and treatment of the metabolic syndrome associated with abdominal obesity.

Author Affiliations: Division of Geriatrics and Nutritional Science, Department of Medicine, Washington University School of Medicine, St Louis, Mo.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Salivary Sex Hormone Measurement in a National, Population-Based Study of Older Adults
Gavrilova and Lindau
J Gerontol B Psychol Sci Soc Sci 2009;0:gbn028v1-gbn028.
ABSTRACT | FULL TEXT  

Depressive Symptoms and Change in Abdominal Obesity in Older Persons
Vogelzangs et al.
Arch Gen Psychiatry 2008;65:1386-1393.
ABSTRACT | FULL TEXT  

Plasma Dehydroepiandrosterone and Risk of Myocardial Infarction in Women
Page et al.
Clin. Chem. 2008;54:1190-1196.
ABSTRACT | FULL TEXT  

Impact of Growth Hormone and Dehydroepiandrosterone on Protein Metabolism in Glucocorticoid-Treated Patients
Burt et al.
J. Clin. Endocrinol. Metab. 2008;93:688-695.
ABSTRACT | FULL TEXT  

Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial
Gurnell et al.
J. Clin. Endocrinol. Metab. 2008;93:400-409.
ABSTRACT | FULL TEXT  

Lack of Dehydroepiandrosterone Effect on a Combined Endurance and Resistance Exercise Program in Postmenopausal Women
Igwebuike et al.
J. Clin. Endocrinol. Metab. 2008;93:534-538.
ABSTRACT | FULL TEXT  

Pre-Operative Modification of Dietary Glycemic Index Improves Pre but Not Post-Operative Indices of Insulin Resistance in Patients Undergoing Coronary Artery Bypass Graft Surgery
Tully et al.
J. Am. Coll. Nutr. 2008;27:168-176.
ABSTRACT | FULL TEXT  

Testosterone Therapy Prevents Gain in Visceral Adipose Tissue and Loss of Skeletal Muscle in Nonobese Aging Men
Allan et al.
J. Clin. Endocrinol. Metab. 2008;93:139-146.
ABSTRACT | FULL TEXT  

DHEA Induces 11 -HSD2 by Acting on CCAAT/Enhancer-Binding Proteins
Balazs et al.
J. Am. Soc. Nephrol. 2008;19:92-101.
ABSTRACT | FULL TEXT  

Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
Roberge et al.
Am. J. Physiol. Endocrinol. Metab. 2007;293:E1465-E1478.
ABSTRACT | FULL TEXT  

Dehydroepiandrosterone Induces Human CYP2B6 through the Constitutive Androstane Receptor
Kohalmy et al.
Drug Metab. Dispos. 2007;35:1495-1501.
ABSTRACT | FULL TEXT  

Two Years of Treatment With Dehydroepiandrosterone Does Not Improve Insulin Secretion, Insulin Action, or Postprandial Glucose Turnover in Elderly Men or Women
Basu et al.
Diabetes 2007;56:753-766.
ABSTRACT | FULL TEXT  

Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study
Maggio et al.
Am. J. Physiol. Endocrinol. Metab. 2007;292:E353-E358.
ABSTRACT | FULL TEXT  

Dehydroepiandrosterone Secretion in Healthy Older Men and Women: Effects of Testosterone and Growth Hormone Administration in Older Men
Muniyappa et al.
J. Clin. Endocrinol. Metab. 2006;91:4445-4452.
ABSTRACT | FULL TEXT  

DHEA enhances effects of weight training on muscle mass and strength in elderly women and men
Villareal and Holloszy
Am. J. Physiol. Endocrinol. Metab. 2006;291:E1003-E1008.
ABSTRACT | FULL TEXT  

DHEA in Elderly Women and DHEA or Testosterone in Elderly Men
Nair et al.
NEJM 2006;355:1647-1659.
ABSTRACT | FULL TEXT  

Aging and Fountain-of-Youth Hormones
Stewart
NEJM 2006;355:1724-1726.
FULL TEXT  

DHEAS Levels and Mortality in Disabled Older Women: The Women's Health and Aging Study I.
Cappola et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2006;61:957-962.
ABSTRACT | FULL TEXT  

Effects of Dehydroepiandrosterone Replacement Therapy on Bone Mineral Density in Older Adults: A Randomized, Controlled Trial
Jankowski et al.
J. Clin. Endocrinol. Metab. 2006;91:2986-2993.
ABSTRACT | FULL TEXT  

Suppressive effects of dehydroepiandrosterone and the nuclear factor-{kappa}B inhibitor parthenolide on corticotroph tumor cell growth and function in vitro and in vivo
Taguchi et al.
J Endocrinol 2006;188:321-331.
ABSTRACT | FULL TEXT  

Androgen therapy in women
Arlt
Eur J Endocrinol 2006;154:1-11.
ABSTRACT | FULL TEXT  

Comparative effects of dehydroepiandrosterone sulfate on ventricular diastolic function with young and aged female mice
Alwardt et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006;290:R251-R256.
ABSTRACT | FULL TEXT  

Is dehydroepiandrosterone a hormone?
Labrie et al.
J Endocrinol 2005;187:169-196.
ABSTRACT | FULL TEXT  

Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue
Apostolova et al.
Am. J. Physiol. Endocrinol. Metab. 2005;288:E957-E964.
ABSTRACT | FULL TEXT